Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests
- 6 July 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 129, 104544
- https://doi.org/10.1016/j.jcv.2020.104544
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical Performance of the Roche SARS-CoV-2 Serologic AssayClinical Chemistry, 2020
- Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total AntibodiesClinical Chemistry, 2020
- Clinical Performance of Two SARS-CoV-2 Serologic AssaysClinical Chemistry, 2020
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet, 2020
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2Journal of Clinical Microbiology, 2020
- A serological assay to detect SARS-CoV-2 seroconversion in humansNature Medicine, 2020
- A Fully Automated Multiplex Assay for Diagnosis of Lyme Disease with High Specificity and Improved Early SensitivityJournal of Clinical Microbiology, 2020
- Differential Sensitivities of Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Polypeptide Enzyme-Linked Immunosorbent Assay (ELISA) and SARS Coronavirus Nucleocapsid Protein ELISA for Serodiagnosis of SARS Coronavirus PneumoniaJournal of Clinical Microbiology, 2005
- Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral NucleocapsidThe Journal of Infectious Diseases, 2004